Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery

2026-04-25
As you wait for stock prices to rebound, these three healthcare companies pay dividends with generous yields.

What You Need to Know Ahead of Medtronic's Earnings Release

2026-04-24
Medtronic is expected to release its fiscal fourth-quarter earnings soon, and analysts project a single-digit profit drop.

Medtronic : Achieves CE Mark for ApexCut ™ Surgical Blades

2026-04-24
April 24, 2026 - Medtronic, a global leader in healthcare technology, today announced CE mark for ApexCut™ surgical blades, the company's next generation of powered ENT instrumentation designed to...

Abbott Laboratories: Buying A Healthcare Giant On Sale

2026-04-24
Abbott (ABT) stock is down ~35% from highs—see Q1 earnings, 2026 EPS guidance, valuation multiples, and a buy-the-dip plan.

Medtronic: Is This Dividend Aristocrat Finally A "Buy" Before Earnings?

2026-04-23
Medtronic plc stock: hold amid slow growth, high debt and competition. Click for this MDT update and a look at recent whether it is a good value after its selloff.

2026 HoustonCISO ORBIE Awards Recognize Top Security Executives

2026-04-23
Leading CISOs honored for leadership, enterprise security, and business impact. HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- The 2026 HoustonCISO ORBIE Awards honored leading chief information security officers (CISOs) from Medtronic, Nabors Industries, Texas Children’s Hospital (fmr), City of Houston, Cornerstone OnDemand, Odfjell Terminals USA, Inc., & SLB for their exceptional leadership. Hosted by HoustonCISO, a chapter of the Inspire Leadership Network, the prestigious awards honor CISOs who

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

2026-04-23
Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an immediate average reduction of 13.2 mmHg in office systolic blood pressure (“oSBP”)97% of patients experienced an immediate blood pressure reduction of >5 mmHg reduction in oSBP prior to randomizationAVIM Therapy demonstrated the potential to deliver immediate, substantial, and sustained reductions in blood

Why BSX Stock's Q1 Beat Is A Lagging Indicator

2026-04-23
The primary insight within Boston Scientific’s (BSX) Q1 2026 results is that the adjusted EPS beat of $0.80 acts as a lagging indicator, contrasting with a moderating trend in forward-looking growth. While management maintained a 28.0% operating margin, the decision to revise full-year 2026 organic revenue guidance from a 10%–11% range to 6.5%–8.0% is the critical signal for investors. This dynamic highlights a strategic divergence from other healthcare leaders. For instance, while our analysis

Texas Instruments' stock jumps 19% for best day since 2000 as AI demand soars

2026-04-23
Texas Instruments beat on earnings and revenue and gave upbeat guidance.

Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun

2026-04-23
The catheter market is poised for significant growth due to rising chronic disease prevalence, increased minimally invasive procedures, and enhanced healthcare access in emerging regions. Opportunities lie in product innovation, particularly in advanced coatings and diagnostic features, and expansion strategies in Asia-Pacific and other developing areas. Catheters Market Catheters Market Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Catheters Market" report has been added to ResearchAndMarkets